The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews
DOI 10.1124/pr.55.3.3

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report
    Kaeley Kaplan, Fiona B. Kurtz, Kelly Serafini · 2018 · Journal of Medical Case Reports
  2. Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control
    Verity Pearson-Dennett, Patrick L. Faulkner, Brittany Collie, Robert A. Wilcox, Adam P. Vogel, Dominic Thewlis, Adrian Esterman, Michelle N. McDonnell, Simon C. Gandevia, Jason M. White et al. · 2019 · Clinical Neurophysiology
  3. Safety and Efficacy of an On-Site Intensive Treatment Protocol for Mild and Moderate Sympathomimetic Toxicity at Australian Music Festivals
    Ned W. R. Douglas, James Carew, Damian Johnson, Madeline Green, Nicholas Wilson, Jake Donovan, Tim Mulherin, Lachlan Holbery‐Morgan, Elyssia M. Bourke, Erin Smith · 2019 · Prehospital and Disaster Medicine
  4. Neuroprotective effects of thymoquinone against MDMA-induced neurotoxicity
    Mustafa NS., Mohamad N., Nor Hidayah Abu Bakar, Mohd Adnan LH., Rohani Jeharsae, Muhammadfahmee Talek, Md. Fauzi NFA., Ahmad NZ. · 2021 · Research Journal of Pharmacy and Technology
  5. PRECLINICAL STUDY: Long‐term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors
    Carola Reinhard, Jochen Wolffgramm · 2006 · Addiction Biology
  6. Phonological Markers of Oxytocin and MDMA Ingestion
    Carla Agurto, Raquel Norel, Rachel Ostrand, Gillinder Bedi, Harriet de Wit, Matthew J. Baggott, Matthew G. Kirkpatrick, Margaret C. Wardle, Guillermo Cecchi · 2017 · Interspeech (USB)
  7. Neonatal Citalopram Treatment Inhibits the 5-HT Depleting Effects of MDMA Exposure in Rats
    Tori L. Schaefer, Curtis E. Grace, Matthew R. Skelton, Devon L. Graham, Gary A. Gudelsky, Charles V. Vorhees, Michael T. Williams · 2011 · ACS Chemical Neuroscience
  8. “The first time I took acid I was in heaven”: a consumer research inquiry into youth illicit drug consumption
    Andrew Smith, James A. Fitchett · 2002 · Management Decision
  9. MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt
    AR Green, CA Marsden, Kevin C.F. Fone · 2008 · Journal of Psychopharmacology
  10. Stimulating Stuff: The Pathological Effects of Cocaine and Amphetamines on the Cardiovascular System
    Michael J Macmahon, Vicky R Tallentire · 2010 · The British Journal of Diabetes
  11. Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons
    Amy K. Goodwin, Melanie Mueller, Courtney D. Shell, George A. Ricaurte, Nancy Almand Ator · 2013 · Journal of Pharmacology and Experimental Therapeutics
  12. Paradoxical effects of low dose MDMA on latent inhibition in the rat
    Andrew J. D. Nelson, K.E. Thur, Charles Alexander Marsden, Helen Joan Cassaday · 2012 · Neuropharmacology
  13. Methamphetamine and MDMA Neurotoxicity: Biochemical and Molecular Mechanisms
    Verónica Bisagno, Jean Lud Cadet · 2014 · Springer eBooks
  14. Common Substances and Medications of Abuse
    William J. Maloney, George F. Raymond · 2015 · Wiley eBooks
  15. Eletroforese capilar como ferramenta analítica para toxicologia forense
    José Luiz Costa · 2008
  16. Long-term neurocognitive side effects of MDMA in recreational ecstasy users following sustained abstinence: A systematic review and meta-analysis
    Hillary Ung, Gemma L. McKeon, Zorica Jokovic, Stephen Parker, Mark Leon Vickers, Eva Malacova, Lars Eriksson, Mark R. C. Daglish · 2025 · Journal of Psychopharmacology
  17. Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT)
    Patricio Sáez‐Briones, Vicente Castro-Castillo, Gabriela Díaz‐Véliz, Luis Valladares, Rafael Barra, Alejandro Hernández, Bruce K. Cassels · 2019 · Frontiers in Pharmacology
  18. Dissemination of Erroneous Research Findings and Subsequent Retraction in High-Circulation Newspapers: A Case Study of Alleged MDMA-Induced Dopaminergic Neurotoxicity in Primates
    Brian Scott Barnett, Rick Doblin · 2020 · Journal of Psychoactive Drugs
  19. Behavioral metabolomics: how behavioral data can guide metabolomics research on neuropsychiatric disorders
    Ross van de Wetering, Jan A. Vorster, Sophie Geyrhofer, Joanne E. Harvey, Robert A. Keyzers, Susan Schenk · 2023 · Metabolomics
  20. Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals
    Chuang‐Hsin Chiu, Kuo‐Hsing Ma, Eagle Yi‐Kung Huang, Hsien-Wen Chang, Shao‐Ju Weng, Tsung-Hsun Yu, Shiou‐Shiow Farn, Yu-Yeh Kuo, Wen-Sheng Huang, Cheng‐Yi Cheng et al. · 2024 · Journal of the Chinese Medical Association
  21. Subdiaphragmatic vagotomy reduces hypothalamic oxytocin expression and blood levels after oral MDMA administration in male rats
    Yong Gang Yue, Xiayun Wan, Guilin Liu, Tingting Zhu, Dan Xu, Mingming Zhao, Yi Cai, Rumi Murayama, Hirofumi Hashimoto, Naohiko Anzai et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  22. Analytical Challenges and Health Implications of “Tusi” (2C): A Critical Review
    Marios C. Christodoulou, Agapios Agapiou, Marinos A. Stylianou · 2025 · Critical Reviews in Analytical Chemistry
  23. Cocaine enhances the conditioned rewarding effects of MDMA in adolescent mice
    M.A. Aguilar, C. Roger-Sánchez, Marta Rodríguez‐Arias, José Miñarro · 2015 · Brain Research Bulletin
  24. Modification of Serial Pattern Learning by Designer Tryptamine Exposure during Adolescence: Comparison with Damage to the Dorsal Hippocampus or Prefrontal Cortex
    David M. Compton, Melissa C. Selinger, Eric Westman, Peter Otero · 2012 · International Journal of Psychology and Behavioral Sciences
  25. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT
    Ratchanee Rodsiri, AR Green, C.A. Marsden, Kevin C.F. Fone · 2009 · Journal of Psychopharmacology
  26. Are ecstasy users biased toward endorsing somatic mental health symptoms? Results from a general community sample
    Amanda M. George, Tim D. Windsor, Bryan Rodgers · 2010 · Psychopharmacology
  27. In Utero Exposure to Nicotine, Cocaine, and Amphetamines
    Lynn T. Singer, Meeyoung Oh Min, Adelaide Lang, Sonia Minnes · 2016 · Springer eBooks
  28. Chemoinformatic Consideration of Novel Psychoactive Substances: Compilation and Preliminary Analysis of a Categorised Dataset
    James W. Firman, Samuel J. Belfield, George Chen, Megan Jackson, Fai Hou Lam, Callum Richmond, James Smith, Fabian Pitter Steinmetz, M Cronin · 2019 · Molecular Informatics
  29. In Vitro Screening of Psychoactive Drugs to Prevent the Abuses
    Kanako Satoh, Ryouichi Nonaka · 2008 · YAKUGAKU ZASSHI
  30. Use characteristics and harm potential of ecstasy in The Netherlands
    Jan van Amsterdam, Johannes Gerardus Ramaekers, Ton Nabben, Wim van den Brink · 2020 · Drugs Education Prevention and Policy
  31. Synergistic effects of MDMA and ethanol on behavior: Possible effects of ethanol on dopamine D2‐receptor‐related signaling
    Tomohisa Mori, Yoshiyuki Iwase, Naoki Uzawa, Yui Takahashi, Ayano Mochizuki, Mika Fukase, Masahiro Shibasaki, Tsutomu Suzuki · 2020 · Addiction Biology
  32. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) in adults
    Marija Franka Žuljević, Marin Viđak, Jakša Vukojević, Darko Hren, Tina Poklepović Peričić · 2022 · Cochrane Database of Systematic Reviews
  33. Acute anxiogenic effects of escitalopram are associated with mild alterations in D-amphetamine-induced behavior and social approach evoked by playback of 50-kHz ultrasonic vocalizations in rats
    Maria Willadsen, Rainer K.W. Schwarting, Markus Wöhr · 2023 · Neuropharmacology
  34. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine
    Candace B Johnson, Donna M. Walther, Matthew J. Baggott, Lisa E. Baker, Michael H. Baumann · 2024 · Journal of Pharmacology and Experimental Therapeutics
  35. The impact of recreational MDMA ‘ecstasy’ use on global form processing
    Claire White, Mark Edwards, John Brown, Jason Bell · 2014 · Journal of Psychopharmacology
  36. 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Intoxication in a Young Adult with Giant Coronary Aneurysms from Kawasaki Disease
    Renee L. Eigsti, Dennis J. Firchau, Marcus B. Nashelsky · 2018 · Academic Forensic Pathology
  37. In Vivo [18F] FDG PET Imaging Reveals that p-Chloroamphetamine Neurotoxicity is Associated with Long-Term Cortical and Hippocampal Hypometabolism
    Luis García‐García, Mercedes Delgado, Ahmed Anis Al-Sayed, Pablo Bascuñana, Rubén Fernández de la Rosa, Paloma Bermejo‐Bescós, Sagrario Martín‐Aragón, Miguel A. Pozo · 2014 · Molecular Imaging and Biology
  38. Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine
    Jung Woo Eun, Seung Jun Kwack, Ji Heon Noh, Kwang Hwa Jung, Jeong Kyu Kim, Hyun Jin Bae, Hongjian Xie, Jae Chun Ryu, Young Min Ahn, Jin-Hye Min et al. · 2009 · Toxicology and Applied Pharmacology
  39. Cocaine and MDMA Induce Cellular and Molecular Changes in Adult Neurogenic Systems: Functional Implications
    Vivian Capilla‐González, Vicente Hernández‐Rabaza · 2011 · Pharmaceuticals
  40. X, Liquid E, and Special K - The Abuse of Drugs at Clubs and Raves
    Frank Romanelli, Kelly M. Smith · 2002 · American Journal of Pharmaceutical Education
  41. Tripping the light fantastic: Modeling the consequences of recreational use of MDMA or 5-MeO-DIPT in humans using weekend “rave” exposures in rat.
    David M. Compton, Friederike S. Luetzenberg, Esther Watkins · 2016 · Psychology & Neuroscience
  42. The Mediating Role of A2A Adenosine Receptors in the Mitochondrial Pathway of Apoptotic Hippocampal Cell Death, Following the Administration of MDMA in Rat
    Masoomeh Bakhshayesh, Fereshteh Golab, Fatemeh Kermanian, Mehdi Mehdizadeh, Amir Reza Katebi, Mansooreh Soleimani, Farzaneh Mohammadzadeh, Ronak Shabani, Elham Movahed, Majid Katebi · 2017 · Basic and Clinical Neuroscience Journal
  43. MDMA related neuro-inflammation and adenosine receptors
    Fatemeh Kermanian, Masoumeh Seghatoleslam, Simin Mahakizadeh · 2022 · Neurochemistry International
  44. Psychische Störungen und Verhaltensstörungen durch psychotrope Substanzen
    Christoph Fehr, Armin Szegedi, Norbert Scherbaum, Eugen Davids, Markus Gastpar, F. Markus Leweke, Carolin Hoyer, Euphrosyne Gouzoulis‐Mayfrank, Markus Lorscheider · 2008 · Springer eBooks
  45. Application of Magnetic Resonance Spectroscopic Imaging to Addiction Research
    Sujung J. Yoon, In Kyoon Lyoo, Perry Franklin Renshaw · 2013 · Wiley eBooks
  46. Tracking Pharmaceuticals and Illicit Drugs in Urban Wastewater: Drug Consumption Trends in Patras, Greece
    Zoi Anastopoulou, Eleni Sazakli, Christoforos Bouzoukas, Marios G. Kostakis, Michalis Leotsinidis, Νikolaos S. Τhomaidis, Apostolos Vantarakis · 2026 · International Journal of Environmental Research
  47. Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use
    Johannes Gerardus Ramaekers, Kim P. C. Kuypers, Franz X. Vollenweider · 2026 · Molecular Psychiatry
  48. Serotonin and Behavioral Stimulant Effects of Addictive Drugs
    Robert J. Carey, Christian P. Müller · 2013 · Elsevier eBooks
  49. Curcumin can improve ecstasy-induced hippocampal damage in rat
    Zahra Nazari, Khadijeh Bahrehbar, Hamid Sepehri, Mohammad Jafar Golalipour · 2023 · Toxicology and Environmental Health Sciences
  50. Sex differences in the effects of N ‐ethylpentylone in young CD1 mice: Insights on behaviour, thermoregulation and early gene expression
    María Espinosa‐Velasco, Adriana Castro‐Zavala, Marina Daiana Reguilón, Inés Gallego‐Landin, Marina Bellot, Olga Rublinetska, Olga Valverde, Marta Rodríguez‐Arias, Núria Nadal‐Gratacós, Xavier Berzosa et al. · 2024 · British Journal of Pharmacology
  51. Alterations to global but not local motion processing in long-term ecstasy (MDMA) users
    Claire White, John Brown, Mark Edwards · 2014 · Psychopharmacology
  52. Dopamine Receptors Gene Expression in Male Rat Hippocampus after Administration of MDMA (Ecstasy)
    Mahakizadeh Simin, Mehrdad Jahanshahi, Kamran Haidari, Majid Shahbazi · 2015 · International Journal of Morphology
  53. Éxtasis (MDMA) y drogas de diseño: estructura, farmacología, mecanismos de acción y efectos en el ser humano
    M. Isabel Colado · 2008 · Trastornos Adictivos
  54. MET Plus CBT for Ecstasy Use When Clients Are Depressed: A Case Series
    Melissa M. Norberg, Ursula Perry, Jennifer Mackenzie, Jan Copeland · 2013 · Cognitive and Behavioral Practice
  55. Particularités des nouvelles drogues
    Frédéric Lapostolle, F. Flesch · 2006 · Réanimation
  56. Challenging the Serotonin System: A Mechanistic Approach to the Method of Acute Tryptophan Depletion in Rodents
    Eva L. van Donkelaar · 2013 · Translational Developmental Psychiatry
  57. Attenuating Glial Activation with Minocycline Reduces the Hyperthermic Response to 3, 4-Methylenedioxymethamphetamine (MDMA) In the Rat
    Paul Anderson · 2011 · The Open Addiction Journal
  58. Assessment of CYP2D6 re-activation after inhibitory effect of MDMA using tramadol as a probe
    Shahin Nilchi, Davood Behdarvand, Hoda Lavasani, Mohammad Reza Rouini, Yalda H. Ardakani · 2018 · Drug Metabolism and Personalized Therapy
  59. MDMA modulates 5-HT1-mediated contractile response of the human internal thoracic artery in vitro
    Diogo A. Fonseca, Cristina Teixeira, Félix Dias Carvalho, Eduarda G. R. Fernandes, Pedro E. Antunes, Manuel Jesus Antunes, Maria Dulce Cotrim · 2018 · Toxicology in Vitro
  60. Investigation of MDMA Inhibitory Effect on CytochromeP450 3A4 in Isolated Perfused Rat Liver Model Using Tramadol
    Behjat Sheikholeslami, Zahra Tootoonchi, Hoda Lavasani, Yalda H. Ardakani, Mohammad Reza Rouini · 2020 · Advanced Pharmaceutical Bulletin
  61. La psychothérapie assistée par la MDMA dans la prise en charge du syndrome de stress post-traumatique
    Baptiste Fauvel, Pascale Piolino · 2021 · Psychologie Française
  62. Anxiety-related Symptoms following the Sporadic Use of Ecstasy – A Case Study
    Tomislav Majić, Lasse Brandt, Christiane Montag · 2021 · Journal of Psychoactive Drugs
  63. Are periodontitis, dental caries and xerostomia more frequently present in recreational ecstasy users?
    Emma E. J. van Kempen, Jan G. A. M. de Visscher, Henk Simon Brand · 2022 · BDJ
  64. Licit use of illicit drugs for treating depression: the pill and the process
    Alejandro Torrado Pacheco, Bita Moghaddam · 2024 · Journal of Clinical Investigation
  65. Neurotoxicity in Psychostimulant and Opiate Addiction
    Ewa Niedzielska, Bartłomiej Rospond, Lucyna Pomierny-Chamioło, Anna Sadakierska−Chudy, Małgorzata Filip · 2021 · Springer eBooks
  66. Engagement with different nightlife venues and frequent ecstasy use in a young adult population
    Ellen M. Leslie, Andrew Smirnov, Adrian Cherney, Helene Wells, Robert Kemp, Margot Legosz, Jake Moses Najman · 2015 · Drugs Education Prevention and Policy
  67. Interspecies In Vitro Evaluation of Stereoselective Protein Binding for 3,4-Methylenedioxymethamphetamine
    Wan Raihana Wan Aasim, Soo Choon Tan, Siew Hua Gan · 2017 · Journal of Chemistry
  68. Life-threatening intoxications related to persistent MDMA (3,4-methylenedioxymethamphetamine) concentrations
    Laura Di Trapani, Céline Eiden, Olivier Mathieu, Caroline Diot, Hélène Donnadieu‐Rigole, Hélène Peyrière · 2017 · Annales de Toxicologie Analytique
  69. Neurotoxicity in Psychostimulant and Opiate Addiction
    Ewa Niedzielska, Bartłomiej Rospond, Lucyna Pomierny-Chamioło, Anna Sadakierska−Chudy, Małgorzata Filip · 2014 · Springer eBooks
  70. Amnésie antérograde consécutive à l’absorption de MDMA et d’alcool : à propos d’un cas
    Caroline Sastre, Marjorie Chèze, Valérie Baillif‐Couniou, Marc Deveaux, Gilbert Pépin, Georges Léonetti, Anne‐Laure Pélissier‐Alicot · 2012 · Annales de Toxicologie Analytique
  71. Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine
    Michael T. Williams, Matthew R. Skelton, Ian D. Longacre, Kimberly N. Huggins, Amanda M. Maple, Charles V. Vorhees, Russell W. Brown · 2014 · Toxicology Reports
  72. Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro
    Marta Barenys, Burkhard Flick, Núria Boix, B. Almeida, Jesús Joglar, Stephan Klug, J.M. Llobet · 2012 · Reproductive Toxicology
  73. Could MDMA Promote Stemness Characteristics in Mouse Embryonic Stem Cells via mGlu5 Metabotropic Glutamate Receptors?
    Rokhsareh Meamar, Fereshteh Karamali, Seyed Ali Mousavi, Hossein Baharvand, Mohammad Hossein Nasr‐Esfahani · 2012 · Europe PMC (PubMed Central)
  74. Long-term neurobiological consequences of ecstasy: A role for pre-existing trait-like differences in brain monoaminergic functioning?
    Alinde E. Wallinga, Sietse F. de Boer, Ramon A. Granneman, Jaap M. Koolhaas, Bauke Buwalda · 2009 · Pharmacology Biochemistry and Behavior
  75. Drugs of abuse on the rise
    Andrea Bulbena‐Cabré, Norma Ramos Dunn, H Kalantari, GW Hassen · 2013 · OA Emergency Medicine
  76. Preprotachykinin A gene expression after administration of 3,4-methylene dioxymethamphetamine (Ecstasy)
    Pierluigi Pompei, Elena Cavazzuti, Daniele Martarelli, Dario Pediconi, Rossana Arletti, Louis Lucas, Maurizio Massi · 2002 · European Journal of Pharmacology
  77. Bruxismo Secundario al Consumo Recreacional de Éxtasis: Revisión de la Literatura
    Daniela Muñoz López, Isaac Maximiliano Bugueno, Fernando Romo Ormazábal, Constanza Garrido Urrutia · 2015 · International journal of odontostomatology
  78. Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA?
    Maurizio Coppola · 2012 · Journal of Addiction Research & Therapy
  79. Neuropsychiatric Complications of Substance Abuse
    George A. Ricaurte, J. William Langston, Una D. McCann · 2008 · Elsevier eBooks
  80. Downregulation of the Vitamin D Receptor Regulated Gene Set in the Hippocampus After MDMA Treatment
    Péter Petschner, Noemi Balogh, Csaba Ádori, Viola Tamási, Sahel Kumar, Gabriella Juhász, György Bagdy · 2018 · Frontiers in Pharmacology
  81. Minocycline attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in the rat brain
    Stefan T. Musolino, Erik P. Schartner, Mark Rowland Hutchinson, Abdallah Salem · 2019 · European Journal of Pharmacology
  82. Bilateral pan-plexus lesion after substance use: A case report
    Dilek Eker Büyükşireci · 2019 · Turkish Journal of Physical Medicine and Rehabilitation
  83. The ameliorating effects of Vitamin E on hepatotoxicity of ecstasy
    Khadije Meghrazi, Masoumeh Zirak Javanmard, Sayed Soran Ghafori, Mojtaba Karimipour · 2020 · Journal of Research in Medical Sciences
  84. Methylenedioxymethamphetamine (Ecstasy, MDMA)
    Nicholas Allan Buckley · 2012
  85. ¿Nuevas drogas de diseño? ¿Nuevas drogas de síntesis?
    X. Claramonte, Santiago Nogué, C. Monsalve · 2002 · FMC - Formación Médica Continuada en Atención Primaria
  86. Methylenedioxymethamphetamine (MDMA)
    Iain S. McGregor, Paul D. Callaghan, Murray R. Thompson · 2014 · Springer eBooks
  87. Post-traumatic stress disorder in psychedelic research
    Tijmen Bostoen, Stephan C. Tap, Joost J. Breeksema, Robert A. Schoevers · 2025 · International review of neurobiology
  88. Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experience
    Rebeca Cohen, João Bastos, Catarina Cunha, M. Marguilho, Ana Valle Sancho, Maria João Matos Silva, Franklin King, Pedro Castro-Rodrigues · 2026 · General Hospital Psychiatry
  89. Serotonin’s fundamental role in early social development: Socio-affective communication through ultrasonic vocalizations, maternal affiliation, and the bidirectional nature of mother-infant interactions
    Tianhua Wang, Markus Wöhr · 2026 · Neuroscience & Biobehavioral Reviews
  90. Computer‐aided (in silico) approaches in the mode‐of‐action analysis and safety assessment of Ostarine and 4‐methylamphetamine
    Fazlin Mohd Fauzi, Alexios Koutsoukas, Andrew Cunningham, Ana Gallegos, Roumen Sedefov, Andreas Bender · 2013 · Human Psychopharmacology Clinical and Experimental
  91. 3,4-Methylenedioxymethamphetamine (Ecstasy) increases the sensitivity of the contractile apparatus to calcium ions in both malignant hyperthermia-susceptible and normal skeletal muscle fibres
    Mark Ulrich Gerbershagen, Goetz Missler, Jan Karl Schütte, Alexander Starosse, Bernhard Martin Graf, Frank Wappler, Wolfgang Zink · 2011 · European Journal of Anaesthesiology
  92. Prelimbic medial prefrontal cortex has bidirectional control over the expression of behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) depending on the context of drug administration
    Jacob A. Plocinski, Kevin T. Ball · 2022 · Neuroscience Letters
  93. Berberine hydrochloride improves cognitive deficiency through hippocampal up-regulation of neurotrophins following inhalant self-administration of methamphetamine.
    Fahimeh Mohseni, Raheleh Rafaiee, Leila Rezaeian, Mohammad Niroumand Sarvandani, Hamid Kalalian Moghaddam · 2023 · PubMed Central
  94. 3,4-Methylenedioxymethamphetamine (MDMA) impairs cognitive function during withdrawal via activation of the arachidonic acid cascade in the hippocampus
    Yoko Nawata, Tsuyoshi Nishioku, Tsuneyuki Yamamoto, Taku Yamaguchi · 2024 · Drug and Alcohol Dependence
  95. Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats
    Gessica Piras, Cristina Cadoni, Francesca Caria, Nicholas Pintori, Enrica Spano, Maksims Vanejevs, Anastasija Ture, Graziella Tocco, Nicola Simola, Maria Antonietta De Luca · 2024 · The International Journal of Neuropsychopharmacology
  96. Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial
    Erica M. Eaton, Christy Capone, Brian J. Gully, Zoe E. Brown, Mollie A. Monnig, Michael S. Worden, Robert M. Swift, Carolina L. Haass‐Koffler · 2024 · Contemporary Clinical Trials Communications
  97. MDMA for treatment of PTSD and neurorehabilitation in military populations
    Walter Dunn, Anya K. Bershad, David E. Krantz, Eric H. G. J. M. Vermetten · 2024 · Neurorehabilitation
  98. Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine—A Systematic Review and Meta-Analysis
    Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar · 2024 · Psychoactives
  99. Ecstasy as a Potential Cause for Diffuse ST Elevation in a 27-Year-Old Healthy Male: A Case Report
    Rabih Nasrallah, Amin Ossaily, Mazen M. Al Hammoud, Anwar Nader, Georges Ghanem · 2025 · Cureus
  100. Ontogeny of Monoamine Neurotransmitters
    Sumit Sarkar, Syed Z. Imam, Jennifer L. Walters · 2018 · Elsevier eBooks